{
    "name": "betamethasone topical",
    "comment": "Rx",
    "other_names": [
        "Diprolene",
        "Luxiq",
        "Dermabet",
        "Alphatrex",
        "Diprolene AF",
        "Diprolene Glycol",
        "Diprosone",
        "Valnac",
        "BetaVal",
        "Sernivo"
    ],
    "classes": [
        "Corticosteroids",
        "Topical"
    ],
    "source": "https://reference.medscape.com/drug/diprolene-luxiq-betamethasone-topical-343515",
    "pregnancy": {
        "common": [
            "There are no available data on ointment use in pregnant women to identify a drug- associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes; observational studies suggest an increased risk of low birthweight infants with the use of greater than 300 grams of potent or very potent topical corticosteroid during a pregnancy; advise pregnant women that the ointment may increase risk of having a low birthweight infant and to use it on the smallest area of skin and for the shortest duration possible"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "In animal reproduction studies, increased malformations, including umbilical hernias, cephalocele, and cleft palate, were observed after intramuscular administration to pregnant rabbits; the available data do not allow calculation of relevant comparisons between systemic exposure in animal studies to systemic exposure that would be expected in humans after topical use of the ointment"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "There are no data regarding the presence of drug in human milk, effects on breastfed infant, or on milk production after topical ointment application to women who are breastfeeding",
            "It is possible that topical administration of betamethasone dipropionate could result in sufficient systemic absorption to produce detectable quantities in human milk; the developmental and health benefits of breastfeeding should be considered along with the motherâ€™s clinical need for therapy and any potential adverse effects on breastfed infant drug or from underlying maternal condition",
            "To minimize potential exposure to breastfed infant via breast milk, use ointment on smallest area of skin and for shortest duration possible while breastfeeding; advise breastfeeding women not to apply ointment directly to nipple and areola to avoid direct infant exposure"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Underlying infection present",
                "Hypersensitivity",
                "Ophthalmic use"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Chronic topical corticosteroid therapy may interfere with growth and development in children",
                "Prolonged treatment with corticosteroids is associated with Kaposi sarcoma (consider discontinuation of therapy if diagnosed)",
                "Discontinue if contact dermatitis occurs; not for use in patients with decreased skin circulation",
                "Manifestations of Cushing syndrome, hyperglycemia, or glycosuria occur, especially if occlusive dressings are used",
                "May increase risk of posterior subcapsular cataracts and glaucoma; cataracts and glaucoma reported postmarketing with use of topical corticosteroid products, including ointment",
                "Use may increase risk of posterior subcapsular cataracts and glaucoma; avoid contact with eyes; advise patients to report any visual symptoms and consider referral to ophthalmologist for evaluation"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Skin atrophy",
            "percent": "2"
        },
        {
            "name": "Striae",
            "percent": null
        },
        {
            "name": "Allergic dermatitis",
            "percent": null
        },
        {
            "name": "Burning",
            "percent": null
        },
        {
            "name": "Dry skin",
            "percent": null
        },
        {
            "name": "Erythema folliculitis",
            "percent": null
        },
        {
            "name": "Hypertrichosis",
            "percent": null
        },
        {
            "name": "Irritation",
            "percent": null
        },
        {
            "name": "Miliaria",
            "percent": null
        },
        {
            "name": "Vesiculation",
            "percent": null
        },
        {
            "name": "Acneform lesions",
            "percent": null
        },
        {
            "name": "Pigmentation changes",
            "percent": null
        },
        {
            "name": "HPA suppression",
            "percent": null
        },
        {
            "name": "with higher potency used",
            "percent": null
        },
        {
            "name": "wk",
            "percent": null
        },
        {
            "name": "Ophthalmic",
            "percent": null
        },
        {
            "name": "Cataracts",
            "percent": null
        },
        {
            "name": "glaucoma",
            "percent": null
        },
        {
            "name": "increased intraocular pressure",
            "percent": null
        },
        {
            "name": "and central serous chorioretinopathy",
            "percent": null
        },
        {
            "name": "Pruritus",
            "percent": null
        },
        {
            "name": "bullous dermatitis",
            "percent": null
        },
        {
            "name": "and erythematous rash",
            "percent": null
        }
    ]
}